SNX19 regulates the number of DCV and insulin content by stabilizing DCV in β-cells. (J Diabetes Invest, doi: 10.1111/j.2040-1124.2011.00138.x, 2012).
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine. This record was last updated on 07/04/2016 and may not reflect the most current and accurate biomedical/scientific data available from NLM. The corresponding record at NLM can be accessed at https://www.ncbi.nlm.nih.gov/pubmed/24843546